Results 101 to 110 of about 185,841 (304)

Acquired immunodeficiency syndrome in Brazil.

open access: yesCroatian medical journal, 2002
To describe the acquired immunodeficiency syndrome (AIDS) epidemic in Brazil and analyze the impact of federal government measures addressing the problem since its onset.Retrospective review of AIDS epidemic data from its onset in 1980 up to the last published data in June 2001.AIDS was first reported in Brazil in 1980. By 1988, all 27 Brazilian states
openaire   +4 more sources

Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes: Design and rationale of the REC1TE trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Compared to people without diabetes, individuals with type 1 diabetes have a several‐fold increased risk of cardiovascular (CV) morbidity and mortality despite guideline‐recommended management of traditional risk factors; so‐called residual CV risk.
David S. Mathiesen   +13 more
wiley   +1 more source

Sensitive detection systems for infectious agents in xenotransplantation*

open access: yesXenotransplantation, EarlyView., 2020
Abstract Xenotransplantation of pig cells, tissues, or organs may be associated with transmission of porcine microorganisms, first of all of viruses, to the transplant recipient, potentially inducing a disease (zoonosis). I would like to define detection systems as the complex of sample generation, sample preparation, sample origin, time of sampling ...
Joachim Denner
wiley   +1 more source

Ketoconazole-resistant Candida esophagitis in patients with acquired immunodeficiency syndrome

open access: bronze, 1986
Avedis Tavitian   +5 more
openalex   +1 more source

Role of remdesivir for the treatment of COVID‐19 in patients with hematologic malignancy—A narrative review and expert opinion

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
Created in BioRender. Ghezzi, S. (2025) https://BioRender.com/q1lticg. Abstract Background COVID‐19 remains a potentially severe condition for immunocompromised individuals, such as patients with hematologic malignancy. These patients are at increased risk of progressing to severe–critical or prolonged COVID‐19.
Malgorzata Mikulska   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy